Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Schering-Plough Corporation
Current Parent Company: Merck
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Recap of Ownership Changes:  subscribe to see this data field
Penalty: $345,000,000
Year: 2004
Date: July 30, 2004
Offense Group: competition-related offenses
Primary Offense: kickbacks and bribery
Secondary Offense: False Claims Act and related
Mega-Scandal: Improper Drug Marketing
Violation Description: The Justice Department announced that Schering Sales Corp., the sales and marketing subsidiary of drug manufacturer Schering-Plough Corporation, had agreed to plead guilty to criminal charges and pay a fine of $52.5 million, while Schering-Plough Corporation was to pay more than $292 million to resolve civil liabilities stemming from its fraudulent pricing of Claritin, its blockbuster allergy medication.
Level of Government: federal
Action Type: agency action
Agency: Justice Department Civil Division
Civil or Criminal Case: civil and criminal
HQ Country of Current Parent: USA
HQ State of Current Parent: New Jersey
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.